JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT CO., LTD.

JiangSu WuZhong Pharmaceutical Development Co., Ltd.

600200

CNE000000YP4

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 16/05/2024 BST			5-day change	1st Jan Change
10.94 ^CNY	-0.55%		-3.78%	+33.09%

04-24	JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-24	JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

JiangSu WuZhong Pharmaceutical Development Co., Ltd. cancelled the transaction announced on November 11, 2021

May 17, 2023

On May 18, 2023, JiangSu WuZhong Pharmaceutical Development Co., Ltd. cancelled the transaction.

Latest news about JiangSu WuZhong Pharmaceutical Development Co., Ltd.

JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-24	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-24	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. cancelled the transaction announced on April 25, 2023	01-03	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Jiangsu WuZhong Pharma to Invest 30 Million Yuan in Local Biotech Firm	26/10/23	MT
Wuzhong Pharmaceutical Development's Unit Gets Registration Certificate for Linezolid Sodium Chloride Injection	18/09/23	MT
JiangSu WuZhong Pharmaceutical Development Co., Ltd.(XSSC:600200) added to S&P Global BMI Index	18/09/23	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	28/08/23	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. cancelled the transaction announced on November 11, 2021	17/05/23	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. announced that it expects to receive CNY 1.2 billion in funding from Zhejiang Fuji Holdings Group Co., Ltd. and other investors	24/04/23	CI
Cinkate Medicine Chemical Intermediate Co., Ltd. agreed to acquire 15% stake in Suzhou Changzheng Cinkate Pharmaceutical Co., Ltd. from JiangSu WuZhong Pharmaceutical Development Co., Ltd. for CNY 33 million.	31/01/23	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/10/22	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	27/04/22	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	26/04/22	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. cancelled the transaction to acquire 70% stake in Shanghai Weina Cosmetics Co., Ltd., from Weina Hongkong Co., Limited.	21/01/22	CI
Jiangsu Wuzhong Pharmaceutical Group Corporation announced that it expects to receive CNY 340 million in funding from JiangSu WuZhong Pharmaceutical Development Co., Ltd.	04/01/22	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. announced that it expects to receive CNY 300 million in funding from Suzhou Fuji Suwu Pharmaceutical Technology Partnership Enterprise (Limited Partnership)	10/11/21	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
JiangSu WuZhong Pharmaceutical Development Co., Ltd. agreed to acquire 70% stake in Shanghai Weina Cosmetics Co., Ltd., from Weina Hongkong Co., Limited.	27/09/21	CI
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	27/08/21	CI
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	28/04/21	CI
Jiangsu Wuzhong Industrial Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2020	30/10/20	CI

Chart JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Duration

Period

Chart JiangSu WuZhong Pharmaceutical Development Co., Ltd.

More charts

JiangSu WuZhong Pharmaceutical Development Co Ltd, formerly Jiangsu Wuzhong Industrial Co Ltd, is a China-based company mainly engaged in pharmaceutical business. The Company's business includes pharmaceuticals, chemicals and real estate. Pharmaceutical business mainly involves pharmaceutical research, development, manufacture and sales. Chemical business mainly includes research, development, manufacture and sales of organic pigments, dyes and intermediates. Its main production varieties are used to produce reactive dyes and organic pigments. Real estate business includes commercial housing and affordable housing.

Sector

Pharmaceuticals

Calendar

26/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.94 CNY

Average target price

12.7 CNY

Spread / Average Target

+16.09%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
JIANGSU WUZHONG PHARMACEUTICAL DEVELOPMENT CO., LTD.	+33.09%	1.07B
ELI LILLY AND COMPANY	+32.34%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.49%	371B
MERCK & CO., INC.	+20.12%	331B
ABBVIE INC.	+7.19%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.66%	169B

Other Pharmaceuticals